Discover the Breakthrough in Early Autism Risk
Detection
NeuroQure's ASD Insight test empowers individuals and physicians with the first-of-its-kind autism risk test. Uncover the risk of autism starting as early as birth.
Current Diagnostic Methods Are Often Too Late or Ineffective
The average diagnosis occurs at 5 years of age, well past critical developmental windows. Traditional tools like the ADOS-2, while considered the "gold standard," face limitations in accessibility, cost, and suitability for children under 24 months or those with motor or sensory disabilities.
Detect autism signs as early as infancy
Enable early interventions for better outcomes
Gain peace of mind with our clinically proven technology
NeuroQure's ASD Insight Identifies Risk Within Days of Birth
NeuroQure’s ASD Insight is a novel test that identifies autism risk within days of birth by detecting a molecular defect in IP3 channel gating through a functional skin biopsy assay. This breakthrough technology enables early detection and intervention, which research shows can lead to an average IQ improvement of over 17 points in toddlers with autism.
ASD Insight By the Numbers
75%
Up to 75% likelihood of predicting autism risk
Weeks
Results available within weeks sample collection
Days
Suitable for those as young as two days old
Read Our Latest Studies
Intracellular Calcium Rysregulation In ASD: An Analysis of Converging Organelle Signaling Pathways
A recent study published in PubMed highlights the critical role of rare inherited genetic variants in contributing to autism risk. Unlike common genetic variations, these rare variants often passed down from parents, can significantly impact neurodevelopment, influencing the likelihood of an ASD diagnosis. Researchers aim to improve early detection and intervention strategies for families at risk by better understanding these inherited genetic factors.
High-Throughput Screen Detects Calcium Signaling Dysfunction in Typical Sporadic ASD
A groundbreaking study reveals that individuals with ASD exhibit distinct metabolic profiles. Using advanced metabolomics analysis, researchers identified significant differences in key metabolic pathways, such as amino acid and lipid metabolism. These findings pave the way for innovative diagnostic tools and therapeutic approaches, offering new insights into the biological underpinnings of ASD.
Detecting Autism Earlier Creates the Best Chance For Successful Treatment
Since science has proven that autism is treatable through effective therapies*, the earlier treatment begins, the better the outcome for the child.
At NeuroQure, we're empowering people with children and physicians alike to transform lives. How? By receiving an accurate diagnosis of risk within days of a skin sample.
The Power of Early Autism Intervention
The Average Age of Diagnosis is 5 Years Old
41% in life-long services cost savings
Apply for qualifying services with traditionally long wait times
Plan ahead for living arrangements, schools, insurance, and more
- The early autism risk detection test is recommended for use in people with an elevated risk for Autism, such as newborns from those with a previous family history, or where there is concern infants are not meeting developmental milestones. The early Autism detection test does not detect all types of Autism and should be used in addition to routine Autism screening tests recommended by a healthcare provider. The early Autism detection test is intended to detect cellular biophysical signals highly correlated with diagnosis of ASD. Use of the early Autism detection test is not recommended in individuals who are pregnant or undergoing active Autism treatment.
- Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Autism Signal Detected” does not rule out Autism; 25% of those with ADOS-diagnosed ASD signal in the neurotypical range. The test interpretation is designed to in this fashion to minimize any false-positive results. A test result of “Autism Signal Detected” requires confirmatory medical diagnostic evaluation or by medically established procedures (e.g. ADOS) to confirm Autism.
- If Autism is not clinically confirmed, it could mean that the patient is still too young to manifest symptoms or that Autism is not present or testing was insufficient to detect Autism, including due to a limited skin sample. False-positive (an autism signal detected when autism is not present) and false-negative (a autism signal not detected when autism is present) test results do occur. Rx only.
Transform Future Outcomes with NeuroQure
Get answers today.